CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jubilant Pharmova Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jubilant Pharmova Ltd
1A, Sector 16A
Phone: +91 1204361000p:+91 1204361000 NOIDA, 201301  India Ticker: JUBLPHARMAJUBLPHARMA
Business Summary
Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company's segments include Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six manufacturing facilities in India, United States and Canada and a network of approximately 48 radio pharmacies in the United States. The Contract Research and Development Services segment provides drug discovery and development services as well as clinical data software and service solutions. The Proprietary Novel Drugs segment is a patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chairman, Non-Executive Director of the Board Hari S.Bhartia 67 5/31/2023
Non-Executive Chairman of the Board Shyam S.Bhartia 70 3/25/2015 3/25/2015
Chief Financial Officer, Whole-Time Director ArvindChokhany 50 6/1/2023 4/1/2021
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Jubilant Industries Limited INDIA
Jubilant Pharma Ltd 6 Temasek Boulevard Singapore
Jubilant Biosys Limited #96, Industrial Suburb 2nd Stage Yeshwantpur Bengaluru India
8 additional Subsidiary records available in full report.

Business Names
Business Name
530019
Cadista Holdings Inc.
Canada Based Draxis Speciality Pharmaceuticals Inc.
16 additional Business Names available in full report.

General Information
Number of Employees: 1,034 (As of 3/31/2023)
Outstanding Shares: 158,350,737 (As of 12/31/2023)
Shareholders: 97,935
Stock Exchange: NSE
Fax Number: +91 1204234881


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024